We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Microplate Readers Market Driven by Rising Incidence of Infectious Diseases

By LabMedica International staff writers
Posted on 14 Dec 2022
Print article
Image: The global microplate readers market is expected to grow at a CAGR of around 12% from 2022-2028 (Photo courtesy of Pexels)
Image: The global microplate readers market is expected to grow at a CAGR of around 12% from 2022-2028 (Photo courtesy of Pexels)

A microplate reader is a laboratory instrument that is used to measure chemical, biological or physical reactions, properties, and analytes within the well of a microplate. A microplate consists of small wells in which separated reactions take place. These reactions convert the presence of an analyte or the progression of biochemical processes into optical signals. The microplate reader detects these signals and thus quantifies the parameter of interest. The market for microplate readers is growing on account of the rising incidence of infectious diseases and increasing adoption of automated platforms in diagnostic laboratories. As a result, the global microplate readers market which was valued at USD 550 million in 2020 is expected to grow at a CAGR of around 12% from 2022-2028. These are the latest findings of UnivDatos Markets Insights (UP, India), a market research firm.

Based on type, the multi-mode microplate readers segment accounted for the largest share of the microplate readers market in 2020 and is expected to register the highest growth during the forecast period owing to their greater flexibility, cost efficiency, and compact sized options. In addition to their fluorescence, absorbance, and luminescence capabilities, these readers also offer different configurable modes for fluorescence polarization, fluorescence resonance energy transfer, etc. Based on application, the genomics & proteomics segment held the largest share of the microplate readers market in 2020 due to an increase in genomics & proteomics research activities, and the availability of a variety of reagent kits and microplate assays for protein library screening and assessment of cell viability. However, the drug discovery segment is also expected to register a strong CAGR during the forecast period.

Based on end-users, the pharmaceutical & biotechnology companies segment accounted for the largest share of the microplate readers market in 2020 and is expected to register the highest growth during the forecast period owing to growing research & development activities in these companies and increasing government support & funding for biotech and pharma research. Geographically, the microplate readers market in North America is expected to register the highest growth during the forecast period due to the well-established healthcare infrastructure, presence of numerous biopharmaceutical and pharmaceutical companies in the region, and increasing focus on drug discovery and higher R&D investments by various pharmaceutical key players.

Related Links:
UnivDatos Markets Insights

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more